Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Coronavirus envelope protein

From Wikipedia, the free encyclopedia
Major structure in coronaviruses
Protein family
Envelope protein
Illustration of a SARS-CoV-2 virion
Model of the external structure of the SARS-CoV-2virion[1]
Blue:envelope
Turquoise:spike glycoprotein (S)
Bright Pink:envelope proteins (E)
Green:membrane proteins (M)
Orange:glycans
Identifiers
SymbolCoV_E
PfamPF02723
InterProIPR003873
PROSITEPS51926
Available protein structures:
Pfam  structures /ECOD  
PDBRCSB PDB;PDBe;PDBj
PDBsumstructure summary

Theenvelope (E) protein is the smallest and least well-characterized of the four majorstructural proteins found incoronavirusvirions.[2][3][4] It is anintegral membrane protein less than 110amino acid residues long;[2] inSARS-CoV-2, the causative agent ofCOVID-19, the E protein is 75 residues long.[5] Although it is not necessarilyessential forviral replication, absence of the E protein may produce abnormally assembledviral capsids or reduced replication.[2][3] E is a multifunctional protein[6] and, in addition to its role as a structural protein in theviral capsid, it is thought to be involved in viral assembly, likely functions as aviroporin, and is involved in viralpathogenesis.[2][5]

Structure

[edit]
Solid-state NMR structure of the pentameric pore formed by thetransmembrane helices of theSARS-CoV-2 E protein, which forms aviroporin permeable tocations.[5][4] Rendered fromPDB:7K3G​.

The E protein consists of a shorthydrophilicN-terminal region, ahydrophobichelicaltransmembrane domain, and a somewhat hydrophilicC-terminal region. InSARS-CoV andSARS-CoV-2, the C-terminal region contains aPDZ-binding motif (PBM).[2][5] This feature appears to beconserved only in thealpha andbeta coronavirus groups, but notgamma.[2] In the beta and gamma groups, a conservedproline residue is found in the C-terminal region likely involved in targeting the protein to theGolgi.[2]

The transmembrane helices of the E proteins of SARS-CoV and SARS-CoV-2 canoligomerize and have been shownin vitro to form pentameric structures with central pores that serve ascation-selectiveion channels.[5] Both viruses' E proteinpentamers have been structurally characterized bynuclear magnetic resonance spectroscopy.[5][7]

Themembrane topology of the E protein has been studied in a number of coronaviruses with inconsistent results; the protein's orientation in the membrane may be variable.[3] The balance of evidence suggests the most common orientation has the C-terminus oriented toward thecytoplasm.[8] Studies of SARS-CoV-2 E protein are consistent with this orientation.[5][9]

Post-translational modifications

[edit]

In some, but not all, coronaviruses, the E protein ispost-translationally modified bypalmitoylation on conservedcysteine residues.[2][8] In the SARS-CoV E protein, oneglycosylation site has been observed, which may influence membrane topology;[8] however, the functional significance of E glycosylation is unclear.[2]Ubiquitination of SARS-CoV E has also been described, though its functional significance is also not known.[2]

Expression and localization

[edit]
Genomic information
Genomic organisation of isolate Wuhan-Hu-1, the earliest sequenced sample of SARS-CoV-2, indicating the location of the E gene
NCBI IDMN908947
Genome size29,903 bases
Year of completion2020
UCSC Genome Browser assembly IDwuhCor1

The E protein isexpressed at high abundance in infected cells. However, only a small amount of the total E protein produced is found in assembledvirions.[2][4] E protein islocalized to theendoplasmic reticulum,Golgi apparatus, andendoplasmic-reticulum–Golgi intermediate compartment (ERGIC), the intracellular compartment that gives rise to the coronavirusviral envelope.[2][5]

Function

[edit]

Essentiality

[edit]

Studies in different coronaviruses have reached different conclusions about whether E isessential to viral replication. In some coronaviruses, includingMERS-CoV, E has been reported to be essential.[10] In others, includingmouse coronavirus[11] and SARS-CoV, E is not essential, though its absence reducesviral titer,[12] in some cases by introducing propagation defects or causing abnormal capsid morphology.[2]

Virions and viral assembly

[edit]
Illustration of a coronavirus virion in therespiratory mucosa, showing the positions of the four structural proteins and components of the extracellular environment[13]

The E protein is found in assembled virions where it formsprotein-protein interactions with thecoronavirus membrane protein (M), the most abundant of the fourstructural proteins contained in theviral capsid.[2][4] The interaction between E and M occurs through their respective C-termini on thecytoplasmic side of the membrane.[2] In most coronaviruses, E and M are sufficient to formvirus-like particles,[2][4] though SARS-CoV has been reported to depend onN as well.[14] There is good evidence that E is involved in inducingmembrane curvature to create the typical spherical coronavirus virion.[2][15] It is likely that E is involved inviral budding or scission, although its role in this process has not been well characterized.[2][4][15]

Viroporin

[edit]
The E viroporin opens at acid pH. The open state in pink presents a wide N-terminus. Conversely, the C-terminus narrows in the open state, which brings the polar sidechains of Thr35 and Arg38 close to the hydrophobic gate at Leu28. This presumedly lowers the energy barrier for ions to cross the channel.

In itspentameric state, E formscation-selectiveion channels and likely functions as aviroporin.[5] NMR studies show that viroporin presents an open conformation at low pH or in the presence of calcium ions, while the closed conformation is favored at basic pH.[16] The NMR structure shows a hydrophobic gate at leucine 28 in the middle of the pore. The passage of ions through the gate is thought to be facilitated by the polar residues at the C-terminus.[17]

The cation leakage may disrupt ionhomeostasis, altermembrane permeability, and modulatepH in the host cell, which may facilitate viral release.[2][4]

The E protein's role as a viroporin appears to be involved inpathogenesis and may be related to activation of theinflammasome.[3][18] In SARS-CoV, mutations that disrupt E's ion channel function result in attenuated pathogenesis inanimal models despite little effect on viral growth.[10]

Interactions with host proteins

[edit]
Cryo-electron microscopy structure of the interaction between theSARS-CoV-2 E protein PDZ-binding motif (magenta) and a construct containing thePDZ (blue),SH3 (yellow), andguanylate kinase-like (GK, green) domains from a host cell protein, humanPALS1[19]

Protein-protein interactions between E and proteins in the host cell are best described inSARS-CoV and occur via the C-terminalPDZ domain binding motif. The SARS-CoV E protein has been reported to interact with five host cell proteins:Bcl-xL,PALS1,syntenin,sodium/potassium (Na+/K+) ATPase α-1 subunit, andstomatin.[2] The interaction with PALS1 may be related to pathogenesis via the resulting disruption intight junctions.[3][10] This interaction has also been identified inSARS-CoV-2.[19]

Evolution and conservation

[edit]

The sequence of the E protein is not wellconserved across coronavirus genera, withsequence identities reaching under 30%.[12] In laboratory experiments onmouse hepatitis virus, substitution of E proteins from different coronaviruses, even from different groups, could produce viable viruses, suggesting that significant sequence diversity can be tolerated in functional E proteins.[20] The SARS-CoV-2 E protein is very similar to that of SARS-CoV, with threesubstitutions and onedeletion.[4] A study of SARS-CoV-2 sequences suggests that the E protein is evolving relatively slowly compared to other structural proteins.[21] The conserved nature of the envelope protein among SARS-CoV and SARS-CoV-2 variants has led it to be researched as a potential target foruniversal coronavirus vaccine development.[22][23]

References

[edit]
  1. ^Solodovnikov, Alexey; Arkhipova, Valeria (2021-07-29)."Достоверно красиво: как мы сделали 3D-модель SARS-CoV-2" [Truly beautiful: how we made the SARS-CoV-2 3D model] (in Russian).N+1. Archived fromthe original on 2021-07-30. Retrieved30 July 2021.
  2. ^abcdefghijklmnopqrstSchoeman D, Fielding BC (May 2019)."Coronavirus envelope protein: current knowledge".Virology Journal.16 (1): 69.doi:10.1186/s12985-019-1182-0.PMC 6537279.PMID 31133031.
  3. ^abcdeSchoeman D, Fielding BC (2020-09-03)."Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature".Frontiers in Microbiology.11: 2086.doi:10.3389/fmicb.2020.02086.PMC 7496634.PMID 33013759.
  4. ^abcdefghCao Y, Yang R, Lee I, Zhang W, Sun J, Wang W, Meng X (June 2021)."Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors".Protein Science.30 (6):1114–1130.doi:10.1002/pro.4075.PMC 8138525.PMID 33813796.
  5. ^abcdefghiMandala VS, McKay MJ, Shcherbakov AA, Dregni AJ, Kolocouris A, Hong M (December 2020)."Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers".Nature Structural & Molecular Biology.27 (12):1202–1208.doi:10.1038/s41594-020-00536-8.PMC 7718435.PMID 33177698.
  6. ^Liu DX, Yuan Q, Liao Y (August 2007)."Coronavirus envelope protein: a small membrane protein with multiple functions".Cellular and Molecular Life Sciences.64 (16):2043–2048.doi:10.1007/s00018-007-7103-1.PMC 7079843.PMID 17530462.
  7. ^Surya W, Li Y, Torres J (June 2018)."Structural model of the SARS coronavirus E channel in LMPG micelles".Biochimica et Biophysica Acta (BBA) - Biomembranes.1860 (6):1309–1317.doi:10.1016/j.bbamem.2018.02.017.PMC 7094280.PMID 29474890.
  8. ^abcFung TS, Liu DX (June 2018)."Post-translational modifications of coronavirus proteins: roles and function".Future Virology.13 (6):405–430.doi:10.2217/fvl-2018-0008.PMC 7080180.PMID 32201497.
  9. ^Duart G, García-Murria MJ, Grau B, Acosta-Cáceres JM, Martínez-Gil L, Mingarro I (September 2020)."SARS-CoV-2 envelope protein topology in eukaryotic membranes".Open Biology.10 (9) 200209.doi:10.1098/rsob.200209.PMC 7536074.PMID 32898469.
  10. ^abcDeDiego ML, Nieto-Torres JL, Jimenez-Guardeño JM, Regla-Nava JA, Castaño-Rodriguez C, Fernandez-Delgado R, et al. (December 2014)."Coronavirus virulence genes with main focus on SARS-CoV envelope gene".Virus Research.194:124–137.doi:10.1016/j.virusres.2014.07.024.PMC 4261026.PMID 25093995.
  11. ^Kuo L, Masters PS (April 2003)."The small envelope protein E is not essential for murine coronavirus replication".Journal of Virology.77 (8):4597–4608.doi:10.1128/JVI.77.8.4597-4608.2003.PMC 152126.PMID 12663766.
  12. ^abRuch TR, Machamer CE (March 2012)."The coronavirus E protein: assembly and beyond".Viruses.4 (3):363–382.doi:10.3390/v4030363.PMC 3347032.PMID 22590676.
  13. ^Goodsell DS, Voigt M, Zardecki C, Burley SK (August 2020)."Integrative illustration for coronavirus outreach".PLOS Biology.18 (8) e3000815.doi:10.1371/journal.pbio.3000815.PMC 7433897.PMID 32760062.
  14. ^Siu YL, Teoh KT, Lo J, Chan CM, Kien F, Escriou N, et al. (November 2008)."The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles".Journal of Virology.82 (22):11318–11330.doi:10.1128/JVI.01052-08.PMC 2573274.PMID 18753196.
  15. ^abJ Alsaadi EA, Jones IM (April 2019)."Membrane binding proteins of coronaviruses".Future Virology.14 (4):275–286.doi:10.2217/fvl-2018-0144.PMC 7079996.PMID 32201500.
  16. ^Medeiros-Silva J, Somberg NH, Wang HK, McKay MJ, Mandala VS, Dregni AJ, Hong M (April 2022)."pH- and Calcium-Dependent Aromatic Network in the SARS-CoV-2 Envelope Protein".Journal of the American Chemical Society.144 (15):6839–6850.doi:10.1021/jacs.2c00973.PMC 9188436.PMID 35380805.
  17. ^Medeiros-Silva J, Dregni AJ, Somberg NH, Duan P, Hong M (October 2023)."Atomic structure of the open SARS-CoV-2 E viroporin".Science Advances.9 (41) eadi9007.doi:10.1126/sciadv.adi9007.PMC 10575589.PMID 37831764.
  18. ^Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Fernandez-Delgado R, et al. (May 2014)."Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis".PLOS Pathogens.10 (5) e1004077.doi:10.1371/journal.ppat.1004077.PMC 4006877.PMID 24788150.
  19. ^abChai J, Cai Y, Pang C, Wang L, McSweeney S, Shanklin J, Liu Q (June 2021)."Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1".Nature Communications.12 (1): 3433.Bibcode:2021NatCo..12.3433C.doi:10.1038/s41467-021-23533-x.PMC 8187709.PMID 34103506.
  20. ^Kuo L, Hurst KR, Masters PS (March 2007)."Exceptional flexibility in the sequence requirements for coronavirus small envelope protein function".Journal of Virology.81 (5):2249–2262.doi:10.1128/JVI.01577-06.PMC 1865940.PMID 17182690.
  21. ^Rahman MS, Hoque MN, Islam MR, Islam I, Mishu ID, Rahaman MM, et al. (March 2021)."Mutational insights into the envelope protein of SARS-CoV-2".Gene Reports.22 100997.doi:10.1016/j.genrep.2020.100997.PMC 7723457.PMID 33319124.
  22. ^Bhattacharya S, Banerjee A, Ray S (March 2021)."Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study".International Journal of Biological Macromolecules.172:74–81.doi:10.1016/j.ijbiomac.2020.12.192.PMC 7833863.PMID 33385461.
  23. ^Chen J, Deng Y, Huang B, Han D, Wang W, Huang M, et al. (2022-02-24)."DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice".Frontiers in Immunology.13 827605.doi:10.3389/fimmu.2022.827605.PMC 8907653.PMID 35281016.
Coronavirus genomes
Viral structural protein
Viral nonstructural protein
(expressed fromORF1ab)
Viral accessory protein
RNA
DNA
linear ds-DNA
(Duplodnaviria,
Varidnaviria)
Herpes simplex
VSPs:
capsid:
VNPs:
Vaccinia
VNPs:
Adenoviridae
VNPs:
circular ds-DNA
(Duplodnaviria,
Varidnaviria?)
Epstein–Barr
VSPs:
VNPs:
ncRNA:
Baculoviridae
VNPs:
other
(Riboviria,
Monodnaviria)
Polyomaviridae
(SV40,MPyV,MCPyV,HaPyV)
(non-enveloped circular ds-DNA)
VSPs:
capsid:
VNPs:
oncoprotein:
Hepatitis B
(circular partially ds-DNA)
VSPs:
VNPs:
RNA
ds-RNA
(Riboviria)
Rotavirus
(Duplornaviricota)
VNPs:
Rhinov.,Polio,Hep A,
etc. (Pisuviricota)
VNPs:
ss-RNA
positive-sense
(Riboviria)
Hepatitis C
(Kitrinoviricota)
VSPs:
VNPs:
SARS-CoV-2
(Pisuviricota)
VSPs:
VNPs:
ss-RNA
negative-sense
(Negarnaviricota)
Influenza virus
VSPs:
capsid:
glycoprotein:
VNPs:
Parainfluenza
VSPs:
glycoprotein:
Mumps
VSPs:
glycoprotein:
Measles
VSPs:
glycoprotein:
RSV
VSPs:
glycoprotein:
Zaire ebolavirus
VSPs:
capsid:
Indiana vesiculovirus
VSPs:
capsid:
RT
Structure and genome of HIV
VSPs:
VRAPs:
Multiple
Fusion protein
oncoprotein:
Retrieved from "https://en.wikipedia.org/w/index.php?title=Coronavirus_envelope_protein&oldid=1321334350"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp